DK0531253T3 - N-substituerede aminomethandiphosphonsyrer - Google Patents

N-substituerede aminomethandiphosphonsyrer

Info

Publication number
DK0531253T3
DK0531253T3 DK92810629.3T DK92810629T DK0531253T3 DK 0531253 T3 DK0531253 T3 DK 0531253T3 DK 92810629 T DK92810629 T DK 92810629T DK 0531253 T3 DK0531253 T3 DK 0531253T3
Authority
DK
Denmark
Prior art keywords
substituted
diphosphonic acids
aminomethane diphosphonic
aminomethane
acids
Prior art date
Application number
DK92810629.3T
Other languages
Danish (da)
English (en)
Inventor
Knut Alfred Dr Jaeggi
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of DK0531253T3 publication Critical patent/DK0531253T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3873Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Dental Preparations (AREA)
DK92810629.3T 1991-08-27 1992-08-18 N-substituerede aminomethandiphosphonsyrer DK0531253T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91810682 1991-08-27

Publications (1)

Publication Number Publication Date
DK0531253T3 true DK0531253T3 (da) 1997-01-27

Family

ID=8208873

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92810629.3T DK0531253T3 (da) 1991-08-27 1992-08-18 N-substituerede aminomethandiphosphonsyrer

Country Status (19)

Country Link
US (1) US5281748A (no)
EP (1) EP0531253B1 (no)
JP (1) JPH05222074A (no)
KR (1) KR930004317A (no)
AT (1) ATE147396T1 (no)
AU (1) AU657983B2 (no)
CA (1) CA2076801A1 (no)
DE (1) DE69216514T2 (no)
DK (1) DK0531253T3 (no)
ES (1) ES2096061T3 (no)
FI (1) FI923797A (no)
GR (1) GR3022243T3 (no)
HU (1) HUT62303A (no)
IL (1) IL102959A (no)
MX (1) MX9204905A (no)
NO (1) NO923331L (no)
NZ (1) NZ244078A (no)
TW (1) TW207543B (no)
ZA (1) ZA926434B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0541037A3 (en) * 1991-11-06 1997-02-26 Takeda Chemical Industries Ltd Squalene synthetase inhibitory composition and use thereof
TW258729B (no) * 1992-06-22 1995-10-01 Ciba Geigy
DE4223940A1 (de) * 1992-07-21 1994-01-27 Boehringer Mannheim Gmbh Neue acyclische Amidingruppen-haltige Diphosphonsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
GB9300641D0 (en) * 1993-01-14 1993-03-03 Zeneca Ltd Process
DE19719680A1 (de) * 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
IT1303672B1 (it) 1998-07-28 2001-02-23 Nicox Sa Sali nitrati di farmaci attivi nei disordini ossei

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2316396C3 (de) * 1973-04-02 1975-09-18 Joh. A. Benckiser Gmbh, 6700 Ludwigshafen N(1,1-Di-phosphono-äthyl)acetamidin, seine Herste lung und Verwendung zur Steinverhütung
DE3208600A1 (de) * 1982-03-10 1983-09-22 Henkel KGaA, 4000 Düsseldorf Amidinodiphosphonsaeuren
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4963681A (en) * 1987-07-06 1990-10-16 Norwich Eaton Pharmaceuticals, Inc. Process for synthesis of aminomethylene phosphonoalkylphosphinates
PH26923A (en) * 1989-03-08 1992-12-03 Ciba Geigy N-substituted amino alkanediphosphonic acids
IE912115A1 (en) * 1990-06-25 1992-01-01 Takeda Chemical Industries Ltd Bisphosphonic acid derivatives, their production and use
US5043099A (en) * 1990-07-13 1991-08-27 Kreh Robert P Mono- and di-substituted (diphosphonoalkylamino methyl)-4-hydroxybenzenesulfonic acid
CA2058012A1 (en) * 1990-12-19 1992-06-20 Takashi Sohda Bisphosphonic acid derivatives, their production and use

Also Published As

Publication number Publication date
DE69216514T2 (de) 1997-07-31
ES2096061T3 (es) 1997-03-01
IL102959A0 (en) 1993-01-31
JPH05222074A (ja) 1993-08-31
MX9204905A (es) 1993-04-01
EP0531253A1 (en) 1993-03-10
HUT62303A (en) 1993-04-28
US5281748A (en) 1994-01-25
CA2076801A1 (en) 1993-02-28
ATE147396T1 (de) 1997-01-15
GR3022243T3 (en) 1997-04-30
IL102959A (en) 1998-01-04
FI923797A (fi) 1993-02-28
EP0531253B1 (en) 1997-01-08
NO923331L (no) 1993-03-01
AU657983B2 (en) 1995-03-30
NZ244078A (en) 1994-12-22
NO923331D0 (no) 1992-08-26
FI923797A0 (fi) 1992-08-24
HU9202754D0 (en) 1992-12-28
KR930004317A (ko) 1993-03-22
AU2128892A (en) 1993-03-04
ZA926434B (en) 1993-04-28
DE69216514D1 (de) 1997-02-20
TW207543B (no) 1993-06-11

Similar Documents

Publication Publication Date Title
NO940038D0 (no) Arylsulfonamido-substituerte hydrokamsyrer
NO924915L (no) Sakkarinderivater med inhiberende virkning paa protolytiske enzymer
MA22014A1 (fr) Derives d'acides amines .
DK0483667T3 (da) Cykliske iminoderivater, lægemidler indholdende disse forbindelser og fremgangsmåde til fremstilling deraf
DK0496378T3 (da) Biphenylderivater, lægemidler indeholdende disse forbindelser og fremgangsmåder til deres fremstilling
FI96204C (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
DE68914292D1 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
DE3851279D1 (de) Organische Salze von Physostigminderivaten.
ES2184960T3 (es) Nuevas pirimidin-4-onas-(5,6)-heteroaril condensadas 2,3 disustituidas.
ATE43834T1 (de) Antimikrobiell wirksame substanzen, ihre herstellung und ihre verwendung.
NZ212768A (en) 2-substituted-1,3-propylidene diphosphonate derivatives and pharmaceutical compositions
DE69216514D1 (de) N-Substituierte Aminomethandiphosphonsäuren
DK0610078T3 (da) Cytotoksisk og antiviral forbindelse.
ATE137759T1 (de) S'-adenosyl-methionin-decarboxylase-inhibitoren
NO178325C (no) Fremgangsmåte for fremstilling av et t-PA injeksjonspreparat
DE3762854D1 (de) Pharmazeutische zusammensetzungen mit inhalt von 5-phenyl-1,3-dioxoalkenylverbindungen.
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central
FI812773L (fi) Foerfarande foer framstaellning av n-/4-/(2,4-diamino-6-pteridinyl)-metyl/metylamino/benzoyl/glutaminsyra
IT1262952B (it) Tetraalchilpiperidine, loro preparazione e loro impiego come stabilizzanti alla luce. (caso 153-5502)